Press release content from Business Wire. The AP news staff was not involved in its creation.
AmbioPharm Inc. Announces New Shanghai Campus Opening and European Executive Team Members
January 7, 2021 GMT
NORTH AUGUSTA, S.C. (BUSINESS WIRE) Jan 7, 2021
AmbioPharm Inc., a worldwide leader in peptide API CDMO services, has recently opened its new Shanghai campus. The new campus adds nearly 50,000 m 2 of manufacturing, quality control and administrative space. “We have added 4 new buildings which add to our solid-phase and liquid-phase peptide facilities at our Shanghai production site positioning AmbioPharm as the go-to source for all peptide API needs that our partners have. This is in addition to the manufacturing expansion which was completed at our USA headquarters in mid-2020,” stated Dr. Chris Bai, CEO and co-founder.